Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow Print PDF (236K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (14)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Wittschieben, J.
Right arrow Articles by Shuman, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wittschieben, J.
Right arrow Articles by Shuman, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, Vol 26, Issue 2 490-496, Copyright © 1998 by Oxford University Press


ARTICLES

Replacement of the active site tyrosine of vaccinia DNA topoisomerase by glutamate, cysteine or histidine converts the enzyme into a site- specific endonuclease

J Wittschieben, BO Petersen and S Shuman
Molecular Biology Program, Sloan-Kettering Institute, New York, NY 10021, USA.

Vaccinia topoisomerase forms a covalent protein-DNA intermediate at 5'- CCCTT downward arrow sites in duplex DNA. The T downward arrow nucleotide is linked via a 3'-phosphodiester bond to Tyr-274 of the enzyme. Here, we report that mutant enzymes containing glutamate, cysteine or histidine in lieu of Tyr-274 catalyze endonucleolytic cleavage of a 60 bp duplex DNA at the CCCTT downward arrow site to yield a 3' phosphate-terminated product. The Cys-274 mutant forms trace levels of a covalent protein-DNA complex, suggesting that the DNA cleavage reaction may proceed through a cysteinyl-phosphate intermediate. However, the His-274 and Glu-274 mutants evince no detectable accumulation of a covalent protein-DNA adduct. Glu-274 is the most active of the mutants tested. The pH dependence of the endonuclease activity of Glu-274 (optimum pH = 6.5) is distinct from that of the wild-type enzyme in hydrolysis of the covalent adduct (optimum pH = 9.5). At pH 6.5, the Glu-274 endonuclease reaction is slower by 5-6 orders of magnitude than the rate of covalent adduct formation by the wild-type topoisomerase, but is approximately 20 times faster than the rate of hydrolysis by the wild-type covalent adduct. We discuss two potential mechanisms to account for the apparent conversion of a topoisomerase into an endonuclease.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
Y. Hwang, N. Minkah, K. Perry, G. D. Van Duyne, and F. D. Bushman
Regulation of Catalysis by the Smallpox Virus Topoisomerase
J. Biol. Chem., December 8, 2006; 281(49): 38052 - 38060.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
G. Woodfield, C. Cheng, S. Shuman, and A. B. Burgin
Vaccinia topoisomerase and Cre recombinase catalyze direct ligation of activated DNA substrates containing a 3'-para-nitrophenyl phosphate ester
Nucleic Acids Res., September 1, 2000; 28(17): 3323 - 3331.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C.-J. Xu, Y.-T. Ahn, S. Pathania, and M. Jayaram
Flp Ribonuclease Activities. MECHANISTIC SIMILARITIES AND CONTRASTS TO SITE-SPECIFIC DNA RECOMBINATION
J. Biol. Chem., November 13, 1998; 273(46): 30591 - 30598.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. O. Krogh and S. Shuman
Vaccinia Topoisomerase Mutants Illuminate Conformational Changes during Closure of the Protein Clamp and Assembly of a Functional Active Site
J. Biol. Chem., September 21, 2001; 276(39): 36091 - 36099.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.